Christopher B. Ehrlich

CIK: 0001293973

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (14.3%)

Derivative conversions

Awards (A)5 (71.4%)

Compensation grants

Other (G, F, J, C, D, …)1 (14.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CERO

CERO THERAPEUTICS HOLDINGS, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

CERO
CERO THERAPEUTICS HOLDINGS, INC.
Jan 7, 2026
Award(A)
Stock Option (Right to Buy)
Direct
4.5M shares-
CERO
CERO THERAPEUTICS HOLDINGS, INC.
May 30, 2025
Award(A)
Stock Option (Right to Buy)
Direct
61.8K shares-
CERO
CERO THERAPEUTICS HOLDINGS, INC.
Mar 4, 2025
Award(A)
Stock Option (Right to Buy)
Direct
119.5K shares-
CERO
CERO THERAPEUTICS HOLDINGS, INC.
Feb 24, 2025
Award(A)
Stock Option (Right to Buy)
Direct
1.3M shares-
CERO
CERO THERAPEUTICS HOLDINGS, INC.
Dec 2, 2024
Award(A)
Stock Option (Right to Buy)
Direct
1.3M shares-
CERO
CERO THERAPEUTICS HOLDINGS, INC.
Sep 30, 2024
Disposition(D)
Stock Option (Right to Buy)
Direct
572.2K shares-
CERO
CERO THERAPEUTICS HOLDINGS, INC.
Sep 25, 2024
Exercise(M)
Direct
5.3M shares-

		Type	Shares	Price		Ownership
Jan 7, 2026	CERO CERO THERAPEUTICS HOLDINGS, INC.	Award(A) Stock Option (Right to Buy)	4,530,997	-	-	Direct
May 30, 2025	CERO CERO THERAPEUTICS HOLDINGS, INC.	Award(A) Stock Option (Right to Buy)	61,843	-	-	Direct
Mar 4, 2025	CERO CERO THERAPEUTICS HOLDINGS, INC.	Award(A) Stock Option (Right to Buy)	119,486	-	-	Direct
Feb 24, 2025	CERO CERO THERAPEUTICS HOLDINGS, INC.	Award(A) Stock Option (Right to Buy)	1,275,000	-	-	Direct
Dec 2, 2024	CERO CERO THERAPEUTICS HOLDINGS, INC.	Award(A) Stock Option (Right to Buy)	1,275,000	-	-	Direct
Sep 30, 2024	CERO CERO THERAPEUTICS HOLDINGS, INC.	Disposition(D) Stock Option (Right to Buy)	572,182	-	-	Direct
Sep 25, 2024	CERO CERO THERAPEUTICS HOLDINGS, INC.	Exercise(M)	5,312,983	-	$0	Direct

1-7 of 7 transactions

About Ehrlich Christopher B

Ehrlich Christopher B (SEC CIK 0001293973) files insider reports with the SEC as Chairman and CEO of CERO THERAPEUTICS HOLDINGS, INC. (CERO).

Signal8 holds 6 ownership filings by Ehrlich Christopher B, all Form 4s, filed between Oct 2, 2024 and Jan 9, 2026. Those filings report 7 transactions, from Sep 25, 2024 to Jan 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ehrlich Christopher B's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Ehrlich Christopher B

Jan 7, 2026: Grant or award of CERO derivative securities (Form 4, code A).
May 30, 2025: Grant or award of CERO derivative securities (Form 4, code A).
Mar 4, 2025: Grant or award of CERO derivative securities (Form 4, code A).
Feb 24, 2025: Grant or award of CERO derivative securities (Form 4, code A).
Dec 2, 2024: Grant or award of CERO derivative securities (Form 4, code A).

Other insiders filing for CERO THERAPEUTICS HOLDINGS, INC. (CERO)

Francois Eric, Director
Rolfe Lindsey, Director
LAPORTE KATHLEEN, Director
Pierce Kristen, Chief Development Officer
Patel Shami, Director
ATWOOD BRIAN G, Director

How to read Form 4 transaction codes